VRTX does what it does best—raising cash; this time it’s a convertible bond offering of up to $400M: http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-2418119250.html?x=0&.v=1 Some kind of public offering was fully expected based on the comments by VRTX’s CFO on recent webcasts.